Search

everythinglearnresearchcommunity

for

Search:↓

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Glucocorticoids for progressive muscular dystrophy in children don't improve muscle strength or function but do increase certain side effects.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Small molecule drugs show promise for advancing regenerative medicine but still face development challenges.

TGF-β signaling is crucial for stem cell maintenance, differentiation, and has implications for cancer treatment.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Asia has made significant progress in tissue engineering and regenerative medicine, but wider clinical use requires more development.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.

The arrector pili muscle might play a role in hair loss and needs more research to understand its impact.

The African spiny mouse can fully regenerate its muscle without scarring, unlike the common house mouse.

Pro-IGF-II improves muscle repair in old mice.

Human body's immune cells are more common in the layer of fat just beneath the skin than in deeper fat layers.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Robotic hair transplantation with AI offers more reliable, precise, and efficient hair restoration.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

A girl with a rare genetic condition affecting hair and nails also developed a common type of hair loss, suggesting a possible genetic link.